Axsome Therapeutics Inc (AXSM)
EBITDA Growth
-9.84%
Quarterly · Period ending:
AXSM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-9.84%period ending
Latest reported-9.84%period ending
AXSM Quarterly EBITDA YoY % (50.27% → -9.84%)
Year-over-year change
High-resolution chart · PNG
AXSM ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -9.8403% | |
| -11.1962% | |
| 65.0105% | |
| 27.847% | |
| 44.0259% | |
| 16.1894% | |
| 26.9232% | |
| -0.3081% | |
| -20.8918% | |
| -1,388.04% | |
| -66.7245% | |
| -49.2687% | |
| -65.9515% | |
| 88.4193% | |
| -79.2544% | |
| -22.1737% | |
| -24.005% | |
| -37.7327% | |
| -16.9066% | |
| -48.0104% | |
| -72.001% | |
| 15.1236% | |
| -13.1297% | |
| -18.9904% | |
| -32.2703% | |
| -212.0645% | |
| -161.5949% | |
| -134.5998% | |
| -68.4507% | |
| -132.4565% | |
| -31.8874% | |
| -31.8026% | |
| -18.3452% | |
| 41.5516% | |
| 0.8777% | |
| 15.5879% | |
| 1.2298% | |
| -30.2881% | |
| -636.9977% | |
| -256.0689% | |
| -227.4701% | |
| -192.4222% | |
| 50.2658% |